Khon Kaen University

Running trials

• Not yet recruiting

  An AI-Based Erythema Measurement System for Psoriasis Lesions

  NCT07494396· Source

• Recruiting

  Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma

  NCT07245238· Phase 3· Source

• Recruiting

  A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  NCT06952504· Phase 3· Source

• Enrolling by invitation

  Efficacy of Topical Cannabidiol for Eczema

  NCT06994520· Phase 2· Source

• Recruiting

  Postoperative Atrial Fibrillation in Cardiac Surgery

  NCT06958029· Source

• Recruiting

  A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

  NCT06841354· Phase 3· Source

• Recruiting

  A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

  NCT06337032· Phase 4· Source

• Recruiting

  Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, Thailand

  NCT05321992· Source

• Recruiting

  COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2

  NCT06396299· Source

• Active, not recruiting

  A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

  NCT06097364· Phase 3· Source

• Active, not recruiting

  Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

  NCT06074588· Phase 3· Source

• Recruiting

  A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

  NCT05744921· Phase 3· Source

• Active, not recruiting

  Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

  NCT05462717· Phase 1· Source

• Active, not recruiting

  A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment

  NCT05133531· Phase 3· Source

• Active, not recruiting

  LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321420· Phase 2· Source

• Active, not recruiting

  Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

  NCT05248646· Phase 3· Source

• Recruiting

  Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

  NCT04375800· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation2 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Endometrial cancer1 recruiting
• HIV1 recruiting
• Liver and biliary tract cancer1 recruiting
• Psoriasis1 recruiting
• Stroke1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Self-management Telehealth Program for Scleroderma

  NCT06990386· Source

• Completed

  Effectiveness of Cannabinoids on Appetite in Scleroderma

  NCT05416697· Phase 3· Source

• Completed

  Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children

  NCT01854775· Phase 2/3· Source

• Completed

  A Prospective Cohort of Children With HIV Infection

  NCT00476606· Source

Trial sites

• Department of Medicine, Faculty of Medicine, Khon Kaen University1 trial
• Department of Pediatrics, Faculty of Medicine, Khon Kaen University1 trial
• Faculty of Medicine Khon Kaen University4 trials
• Faculty of Medicine - Khon Kaen University (Site 0903)1 trial
• Faculty of Medicine - Khon Kaen University (Site 3803)1 trial
• Faculty of Medicine - Khon Kaen University (Site 4004)1 trial
• Faculty of Medicine - Khon Kaen University (Site 5802)1 trial
• Khon Kaen University9 trials
• Khon Kaen University - Site #1731 trial
• Khon Kaen University1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Liver and biliary tract cancer91 works · 1 trials
• Thalassaemia19 works · 0 trials
• Systemic sclerosis (scleroderma)19 works · 3 trials